Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 1.85% is 122% above its 5-year average of -8.54%, near the low end of its 5-year range (-22.77%–137.82%).
283.73% above its 12-month average of 0.48%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 5.83%.
NET PROFIT MARGIN
1.85%
NET PROFIT MARGIN AVG TTM
0.48%
NET PROFIT MARGIN AVG 3Y
-4.99%
NET PROFIT MARGIN AVG 5Y
-8.54%
NET PROFIT MARGIN AVG 10Y
-12.92%
NET PROFIT MARGIN AVG 15Y
-13.53%
NET PROFIT MARGIN AVG 20Y
-15.05%
CURRENT VS TTM AVG
+283.73%
CURRENT VS 3Y AVG
+137.06%
CURRENT VS 5Y AVG
+121.67%
CURRENT VS 10Y AVG
+114.32%
CURRENT VS 15Y AVG
+113.67%
CURRENT VS 20Y AVG
+112.29%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 508 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$2.90B
Net Profit Margin
22.69%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$2.89B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.76B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
Market Cap
$2.69B
Net Profit Margin
-40.18%
TTM Avg
-20.09%
3Y Avg
-20.09%
5Y Avg
-20.09%
Market Cap
$2.68B
Net Profit Margin
-33.44%
TTM Avg
-12.59%
3Y Avg
-3.87%
5Y Avg
-6.56%
Market Cap
$2.68B
Net Profit Margin
10.56%
TTM Avg
9.25%
3Y Avg
0.54%
5Y Avg
-8.48%
Market Cap
$3.15B
Net Profit Margin
6.15%
TTM Avg
-37.77%
3Y Avg
-2241.27%
5Y Avg
-1494.18%
Market Cap
$3.16B
Net Profit Margin
-14191.20%
TTM Avg
0.00%
3Y Avg
-86.13%
5Y Avg
-153.41%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AtriCure, Inc. (ATRC) | $2.85B | 1.85% | 0.48% | -4.99% | -8.54% |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 22.69% | 19.73% | -2.42% | -44.65% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | 0.00% | 0.00% | 0.00% | 0.00% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | -54.75% | -325.19% | -290.00% | -135445.82% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.69B | -40.18% | -20.09% | -20.09% | -20.09% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | -33.44% | -12.59% | -3.87% | -6.56% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 10.56% | 9.25% | 0.54% | -8.48% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 6.15% | -37.77% | -2241.27% | -1494.18% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | -14191.20% | 0.00% | -86.13% | -153.41% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.18B | 0.00% | -172.68% | -306.20% | -1288.24% |
Operating Margin
2.4%
Net Profit Margin
1.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 5.83% |
| 2026-03-31 | 0.08% |
| 2025-12-31 | 1.25% |
| 2025-09-30 | -0.20% |
| 2025-06-30 | -4.55% |
| 2025-03-31 | -5.46% |
| 2024-12-31 | -12.53% |
| 2024-09-30 | -6.78% |
| 2024-06-30 | -6.89% |
| 2024-03-31 | -12.19% |
| 2023-12-31 | -9.19% |
| 2023-09-30 | -9.21% |
| 2023-06-30 | -5.07% |
| 2023-03-31 | -6.93% |
| 2022-12-31 | -4.74% |
| 2022-09-30 | -14.74% |
| 2022-06-30 | -17.56% |
| 2022-03-31 | -20.36% |
| 2021-12-31 | -18.77% |
| 2021-09-30 | 137.82% |
| 2021-06-30 | -22.77% |
| 2021-03-31 | -28.54% |
| 2020-12-31 | -32.16% |
| 2020-09-30 | -9.04% |
| 2020-06-30 | -20.17% |
| 2020-03-31 | -30.83% |
| 2019-12-31 | -26.25% |
| 2019-09-30 | -16.54% |
| 2019-06-30 | -6.96% |
| 2019-03-31 | -10.44% |
| 2018-12-31 | -6.48% |
| 2018-09-30 | -14.49% |
| 2018-06-30 | -0.65% |
| 2018-03-31 | -21.56% |
| 2017-12-31 | -5.60% |
| 2017-09-30 | -17.19% |
| 2017-06-30 | -15.22% |
| 2017-03-31 | -24.67% |
| 2016-12-31 | -20.96% |
| 2016-09-30 | -17.69% |
| 2016-06-30 | -20.68% |
| 2016-03-31 | -27.06% |
| 2015-12-31 | -30.43% |
| 2015-09-30 | -19.54% |
| 2015-06-30 | -15.01% |
| 2015-03-31 | -17.62% |
| 2014-12-31 | -18.17% |
| 2014-09-30 | -1.75% |
| 2014-06-30 | -10.15% |
| 2014-03-31 | -31.03% |
| 2013-12-31 | -22.76% |
| 2013-09-30 | -13.64% |
| 2013-06-30 | -8.77% |
| 2013-03-31 | -10.00% |
| 2012-12-31 | -11.00% |
| 2012-09-30 | -15.91% |
| 2012-06-30 | -7.26% |
| 2012-03-31 | -9.27% |
| 2011-12-31 | -12.40% |
| 2011-09-30 | -7.60% |
| 2011-06-30 | -5.64% |
| 2011-03-31 | -8.14% |
| 2010-12-31 | 0.07% |
| 2010-09-30 | -7.11% |
| 2010-06-30 | -5.39% |
| 2010-03-31 | -14.40% |
| 2009-12-31 | -17.32% |
| 2009-09-30 | -35.37% |
| 2009-06-30 | -10.47% |
| 2009-03-31 | -58.25% |
| 2008-12-31 | -26.51% |
| 2008-09-30 | -11.96% |
| 2008-06-30 | -10.72% |
| 2008-03-31 | -26.65% |
| 2007-12-31 | -11.90% |
| 2007-09-30 | -21.55% |
| 2007-06-30 | -22.56% |
| 2007-03-31 | -40.02% |
| 2006-12-31 | -40.22% |
| 2006-09-30 | -33.72% |
| 2006-06-30 | -33.25% |
| 2006-03-31 | -35.77% |
| 2005-12-31 | -46.85% |
| 2005-09-30 | -55.29% |
| 2005-06-30 | -30.31% |
| 2005-03-31 | -31.56% |
| 2004-12-31 | -111.94% |
| 2004-09-30 | -37.46% |
| 2004-06-30 | -3.85% |
